Key Takeaways XRAY rose nearly 7.8% pre-market despite a Q4 earnings miss and margin contraction.DENTSPLY SIRONA posted 6.2% Q4 revenue growth, beating estimates on sales recovery.XRAY unveiled a $120M cost-saving restructuring and will halt dividends to cut debt.DENTSPLY SIRONA Inc. (XRAY) reported fourth-quarter 2025 adjusted earnings per share (EPS) of 27 cents, up 3.8% year over year. The bottom line missed the Zacks Consensus Estimate by 3.6%.GAAP loss per share in the quarter under review was 74 cents ...